long intergenic non-protein coding RNA 1030Genealiases: []
Q-omics provides the consensus-scored LINC01030 profile across patient tissues and cancer cell-line models. LINC01030 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC01030 is differentially expressed in 7, with the highest sampling consensus in LIHC. Additionally, LINC01030 RNA expression shows 7,962 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and LIHC as cancer lineages where LINC01030 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01030 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01030 survival associations across molecular data types. LINC01030 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01030 RNA expression–survival associations across cancer types. High LINC01030 expression shows unfavorable associations in UVM, THYM, LUSC, LUAD and OV, but favorable associations in ESCA. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC01030 RNA expression.
This table summarizes LINC01030 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01030. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01030 shows lower tumor expression in ESCA, THCA and LUSC and higher tumor expression in LIHC, KIRC and BLCA. The LIHC box plot shows higher LINC01030 RNA expression in tumor versus normal tissue (log2 FC = +0.033, t-test p = .008).
This table shows molecular features associated with LINC01030 in patient tissues and cancer cell lines. In patient samples, LINC01030 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
